Variable | No. of patients (%) |
---|---|
Age (years; Median (range) | 61 (37–76) |
Cutaneous primary | 21 (70) |
Unknown primary | 8 (27) |
Mucosal | 1 (3) |
Gender | |
Female | 12 (40) |
Male | 18 (60) |
Performance status | |
0 | 16 (53) |
1 | 14 (47) |
Recurrent disease after prior surgery | 15 (50) |
Presence of in-transit metastases | 16 (53) |
Prior adjuvant HDI | 5 (17) |
Estimated risk Stage | |
IIIB | 3 (10) |
IIIC | 25 (83) |
IV (Not eligible) | 2 (7) |